- Home
- App Analytics
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. Multiple Myeloma [MM]
Multiple Myeloma Management vs Multiple Myeloma [MM] Uso e estatísticas
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Multiple Myeloma @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Multiple Myeloma content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
Multiple Myeloma Management versus Multiple Myeloma [MM] comparação de classificação
Compare a tendência de classificação de Multiple Myeloma Management nos últimos 28 dias versus Multiple Myeloma [MM]
Classificação
Nenhum dado disponível
Comparação da classificação de Multiple Myeloma Management vs. Multiple Myeloma [MM] por país
Compare a tendência de classificação de Multiple Myeloma Management nos últimos 28 dias versus Multiple Myeloma [MM]
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
Multiple Myeloma Management VS.
Multiple Myeloma [MM]
19ezembro d, 2024